{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T16:54:10Z","timestamp":1649177650863},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1097\/mca.0000000000000642","type":"journal-article","created":{"date-parts":[[2018,6,17]],"date-time":"2018-06-17T10:44:56Z","timestamp":1529232296000},"page":"516-525","source":"Crossref","is-referenced-by-count":3,"title":["Impact of serum lipoprotein(a) on endothelium-dependent coronary vasomotor response assessed by intracoronary acetylcholine provocation"],"prefix":"10.1097","volume":"29","author":[{"given":"Ahmed","family":"Mashaly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Geol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man Jong","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Gi","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Kyeong","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem","family":"Abdelshafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoonjee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Woohyeun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jah Yeon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Oh","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Ung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Euy","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eung Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Seog","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210204","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00041433-200404000-00009","article-title":"Structure-function relationships in apolipoprotein(a): Insights into lipoprotein(a) assembly and pathogenicity","volume":"15","author":"Koschinsky","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"R2-11-20210204","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"R3-11-20210204","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1253\/circj.66.267","article-title":"Association between plasma lipoprotein(a) and endothelial dysfunction in normocholesterolemic and non-diabetic patients with angiographically normal coronary arteries","volume":"66","author":"Ioka","year":"2002","journal-title":"Circ J"},{"key":"R4-11-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0021-9150(00)00411-1","article-title":"Lipoprotein (a) is associated with endothelial function in healthy postmenopausal women","volume":"153","author":"Wilmink","year":"2000","journal-title":"Atherosclerosis"},{"key":"R5-11-20210204","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"R6-11-20210204","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1161\/CIRCULATIONAHA.108.843474","article-title":"Coronary artery spasm: a 2009 update","volume":"119","author":"Stern","year":"2009","journal-title":"Circulation"},{"key":"R7-11-20210204","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM198610233151702","article-title":"Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries","volume":"315","author":"Ludmer","year":"1986","journal-title":"N Engl J Med"},{"key":"R8-11-20210204","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF02058755","article-title":"Usefulness of intracoronary injection of acetylcholine as a provocative test for coronary artery spasm in patients with vasospastic angina","volume":"6","author":"Miwa","year":"1991","journal-title":"Heart Vessels"},{"key":"R9-11-20210204","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0735-1097(88)90449-4","article-title":"Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm","volume":"12","author":"Okumura","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"R10-11-20210204","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/clc.22403","article-title":"Overview of the acetylcholine spasm provocation test","volume":"38","author":"Sueda","year":"2015","journal-title":"Clin Cardiol"},{"key":"R11-11-20210204","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jacc.2013.10.038","article-title":"Provocative testing for coronary reactivity and spasm","volume":"63","author":"Zaya","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R12-11-20210204","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacc.2008.04.008","article-title":"Role of lipoprotein(a) in cardiovascular disease. Current and future perspectives","volume":"52","author":"Berglund","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R13-11-20210204","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/eurheartj\/ehx166","article-title":"Lipoprotein(a) and the risk of cardiovascular disease in the european population: results from the biomarcare consortium","volume":"38","author":"Waldeyer","year":"2017","journal-title":"Eur Heart J"},{"key":"R14-11-20210204","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1194\/jlr.M008961","article-title":"Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy","volume":"51","author":"Nicholls","year":"2010","journal-title":"J Lipid Res"},{"key":"R15-11-20210204","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 esc\/eas guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"R16-11-20210204","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/jhh.2009.40","article-title":"Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test","volume":"24","author":"Chen","year":"2010","journal-title":"J Hum Hypertens"},{"key":"R17-11-20210204","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.amjcard.2007.05.030","article-title":"Comparison of frequency of coronary spasm in korean patients with versus without myocardial bridging","volume":"100","author":"Kim","year":"2007","journal-title":"Am J Cardiol"},{"key":"R18-11-20210204","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"R19-11-20210204","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1253\/circj.CJ-10-74-0802","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (jcs 2008): digest version","volume":"74","author":"Ogawa","year":"2010","journal-title":"Circ J"},{"key":"R20-11-20210204","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1440-1681.2011.05611.x","article-title":"Multivessel versus single vessel spasm, as assessed by the intracoronary acetylcholine provocation test, in korean patients","volume":"38","author":"Park","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R21-11-20210204","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","article-title":"Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study","volume":"32","author":"Gurdasani","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R22-11-20210204","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"The Emerging Risk Factors C: lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"R23-11-20210204","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/archinte.168.6.598","article-title":"Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data","volume":"168","author":"Bennet","year":"2008","journal-title":"Arch Intern Med"},{"key":"R24-11-20210204","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.102.10.1082","article-title":"Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies","volume":"102","author":"Danesh","year":"2000","journal-title":"Circulation"},{"key":"R25-11-20210204","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jama.296.11.1363","article-title":"Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women","volume":"296","author":"Suk Danik","year":"2006","journal-title":"JAMA"},{"key":"R26-11-20210204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: The atherosclerosis risk in communities (aric) study","volume":"125","author":"Virani","year":"2012","journal-title":"Circulation"},{"key":"R27-11-20210204","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.hjr.0000087080.83314.be","article-title":"Plasma lipoprotein lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease","volume":"10","author":"Imhof","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"R28-11-20210204","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCULATIONAHA.107.715698","article-title":"Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the copenhagen city heart study","volume":"117","author":"Kamstrup","year":"2008","journal-title":"Circulation"},{"key":"R29-11-20210204","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"R30-11-20210204","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/cvr\/cvu107","article-title":"Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts","volume":"103","author":"Laschkolnig","year":"2014","journal-title":"Cardiovasc Res"},{"key":"R31-11-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1078-5884(97)80220-1","article-title":"Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease","volume":"14","author":"Cheng","year":"1997","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R32-11-20210204","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/BF02002128","article-title":"Lipoprotein (a): a risk factor for peripheral vascular disease","volume":"7","author":"Widmann","year":"1993","journal-title":"Ann Vasc Surg"},{"key":"R33-11-20210204","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.atherosclerosissup.2015.02.032","article-title":"Lipoprotein apheresis in patients with peripheral artery disease and hyperlipoproteinemia(a)","volume":"18","author":"Poller","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"R34-11-20210204","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/0735-1097(95)00321-5","article-title":"Influence of plasma lipoprotein (a) levels on coronary vasomotor response to acetylcholine","volume":"26","author":"Tsurumi","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R35-11-20210204","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0735-1097(97)00237-4","article-title":"Lipoprotein(a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation","volume":"30","author":"Schachinger","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R36-11-20210204","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00380-013-0346-x","article-title":"Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm","volume":"29","author":"Nishino","year":"2014","journal-title":"Heart Vessels"},{"key":"R37-11-20210204","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: The multi-ethnic study of atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R38-11-20210204","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/1440-1681.12396","article-title":"Impact of high lipoprotein(a) levels on in-stent restenosis and long-term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug-eluting stents in asian population","volume":"42","author":"Park","year":"2015","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R39-11-20210204","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12944-016-0258-8","article-title":"The relationship between lp(a) and cvd outcomes: a systematic review","volume":"15","author":"Forbes","year":"2016","journal-title":"Lipid Health Dis"},{"key":"R40-11-20210204","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjcard.2014.10.015","article-title":"Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention","volume":"115","author":"Konishi","year":"2015","journal-title":"Am J Cardiol"},{"key":"R41-11-20210204","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.amjcard.2016.08.067","article-title":"Impact of lipoprotein(a) on long-term outcomes in patients with diabetes mellitus who underwent percutaneous coronary intervention","volume":"118","author":"Konishi","year":"2016","journal-title":"Am J Cardiol"},{"key":"R42-11-20210204","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0735-1097(02)02267-2","article-title":"Global Evaluation of New Events and Restenosis After Stent Implantation Study Group. The impact of plasma levels of c-reactive protein, lipoprotein (a) and homocysteine on the long-term prognosis after successful coronary stenting: The global evaluation of new events and restenosis after stent implantation study","volume":"40","author":"Zairis","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:57Z","timestamp":1620960177000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201809000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000642","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}